[HTML][HTML] The use of 2-D speckle tracking echocardiography in differentiating healthy adolescent athletes with right ventricular outflow tract dilation from patients with …

DM Dorobantu, N Riding, G McClean… - International Journal of …, 2023 - Elsevier
DM Dorobantu, N Riding, G McClean, MS de la Garza, M Abuli-Lluch, C Sharma, N Duarte…
International Journal of Cardiology, 2023Elsevier
Aims Echocardiographic assessment of adolescent athletes for arrhythmogenic
cardiomyopathy (ACM) can be challenging owing to right ventricular (RV) exercise-related
remodelling, particularly RV outflow tract (RVOT) dilation. The aim of this study is to evaluate
the role of RV 2-D speckle tracking echocardiography (STE) in comparing healthy
adolescent athletes with and without RVOT dilation to patients with ACM. Methods and
results A total of 391 adolescent athletes, mean age 14.5±1.7 years, evaluated at three …
Aims
Echocardiographic assessment of adolescent athletes for arrhythmogenic cardiomyopathy (ACM) can be challenging owing to right ventricular (RV) exercise-related remodelling, particularly RV outflow tract (RVOT) dilation. The aim of this study is to evaluate the role of RV 2-D speckle tracking echocardiography (STE) in comparing healthy adolescent athletes with and without RVOT dilation to patients with ACM.
Methods and results
A total of 391 adolescent athletes, mean age 14.5 ± 1.7 years, evaluated at three sports academies between 2014 and 2019 were included, and compared to previously reported ACM patients (n = 38 definite and n = 39 borderline). Peak systolic RV free wall (RVFW-Sl), global and segmental strain (Sl), and corresponding strain rates (SRl) were calculated. The participants meeting the major modified Task Force Criteria (mTFC) for RVOT dilation were defined as mTFC+ (n = 58, 14.8%), and the rest as mTFC- (n = 333, 85.2%). Mean RVFW-Sl was −27.6 ± 3.4% overall, −28.2 ± 4.1% in the mTFC+ group and − 27.5 ± 3.3% in the mTFC- group. mTFC+ athletes had normal RV-FW-Sl when compared to definite (−29% vs −19%, p < 0.001) and borderline ACM (−29% vs −21%, p < 0.001) cohorts. In addition, all mean global and regional Sl and SRl values were no worse in the mTFC+ group compared to the mTFC- (p values range < 0.0001 to 0.1, inferiority margin of 2% and 0.1 s−1 respectively).
Conclusions
In athletes with RVOT dilation meeting the major mTFC, STE evaluation of the RV can demostrate normal function and differentiate physiological remodelling from pathological changes found in ACM, improving screening in grey-area cases.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果